Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

IntriCon Corporation

IINNASDAQ
Healthcare
Medical - Instruments & Supplies
$24.23
$0.03(0.12%)
U.S. Market opens in 17h 19m

IntriCon Corporation Fundamental Analysis

IntriCon Corporation (IIN) shows weak financial fundamentals with a PE ratio of -3438.39, profit margin of -0.05%, and ROE of -0.07%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-34.38
Current Ratio3.68

Areas of Concern

ROE-0.07%
Operating Margin0.04%
We analyze IIN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 36.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
36.2/100

We analyze IIN's fundamental strength across five key dimensions:

Efficiency Score

Weak

IIN struggles to generate sufficient returns from assets.

ROA > 10%
-0.05%

Valuation Score

Excellent

IIN trades at attractive valuation levels.

PE < 25
-3438.39
PEG Ratio < 2
-34.38

Growth Score

Moderate

IIN shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IIN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.06
Current Ratio > 1
3.68

Profitability Score

Weak

IIN struggles to sustain strong margins.

ROE > 15%
-6.93%
Net Margin ≥ 15%
-0.05%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is IIN Expensive or Cheap?

P/E Ratio

IIN trades at -3438.39 times earnings. This suggests potential undervaluation.

-3438.39

PEG Ratio

When adjusting for growth, IIN's PEG of -34.38 indicates potential undervaluation.

-34.38

Price to Book

The market values IntriCon Corporation at 2.35 times its book value. This may indicate undervaluation.

2.35

EV/EBITDA

Enterprise value stands at 0.06 times EBITDA. This is generally considered low.

0.06

How Well Does IIN Make Money?

Net Profit Margin

For every $100 in sales, IntriCon Corporation keeps $-0.05 as profit after all expenses.

-0.05%

Operating Margin

Core operations generate 0.04 in profit for every $100 in revenue, before interest and taxes.

0.04%

ROE

Management delivers $-0.07 in profit for every $100 of shareholder equity.

-0.07%

ROA

IntriCon Corporation generates $-0.05 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.05%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.23 in free cash annually.

$-0.23

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3438.39

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-34.38

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.35

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.68

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.00

vs 25 benchmark

How IIN Stacks Against Its Sector Peers

MetricIIN ValueSector AveragePerformance
P/E Ratio-3438.3929.43 Better (Cheaper)
ROE-0.07%800.00% Weak
Net Margin-0.05%-20145.00% (disorted) Weak
Debt/Equity0.060.30 Strong (Low Leverage)
Current Ratio3.684.64 Strong Liquidity
ROA-0.05%-17936.00% (disorted) Weak

IIN outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IntriCon Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ